Gene Editing

Gene Editing

Products & Services

Information

Building a successful gene editing therapy program faces numerous challenges at every step, from discovery through clinical stages and, ultimately, commercialization. From identifying precise genetic targets and optimizing gene editing tools, to navigating preclinical and clinical trials, you need access to cutting-edge tools, high-quality materials, and expert support. Aldevron's comprehensive solutions empower drug developers to turn innovative ideas into life-changing treatments. Together, we pave the way for a future where genetic disorders can be effectively treated and lead to life-changing cures. https://www.aldevron.com/modalities/gene-editing
Aldevron119Founded in 1998, Aldevron is a global leader in enabling the development of next-generation genomic medicines. As part of Danaher Corporation (NYSE: DHR) family of global science and technology companies, Aldevron empowers scientists and innovators worldwide to advance transformative therapies that are redefining the future of medicine. Aldevron’s expertise and integrated solutions have supported landmark achievements—including playing a key role in manufacturing the world’s first mRNA-based personalized CRISPR therapy. With facilities in Fargo, ND, Madison, WI and Waltham, MA, Aldevron is at the forefront of accelerating scientific discovery and expanding the possibilities of gene editing, gene therapy and other breakthrough modalities. By partnering with leading researchers and organizations, Aldevron is helping to turn the promise of genomic medicine into reality for patients around the globe.

Log in

See all the content and easy-to-use features by logging in or registering!